Epigenetic Therapy

Epigenetic therapy is meant to use the drugs or epigenome-influencing techniques to treat medical states. Histone deactylases (HDACs), which modify histones, and DNA methyltransferases (DNMTs), which methylate DNA are the two enzymes that are important in epigenetic modifications and key targets for therapy with pharmaceutical drugs. Successful clinical studies carried out for both the enzymes. Epigenetic therapy has shown a strong effectiveness against hematological malignancies and solid tumors, gaining FDA approval for cutaneous T-cell lymphoma, ER-positive metastatic breast cancer, myelodysplastic syndrome, multiple myeloma, and peripheral T-cell lymphoma. Epigenetic therapy has proven successful for several types of cancer, including lung cancer, breast cancer, and lymphoma.

  • Fear
  • Anxiety
  • Trauma
  • Schizophrenia
  • Cardiac dysfunction
  • Pharmacokinetics epigenetics

Related Conference of Epigenetic Therapy

August 22-23, 2019

5th International Congress on Epigenetics & Chromatin

Vienna, Austria
August 30-31, 2019

International Conference on Genetic Disorders

Bangkok, Thailand
September 13-14, 2019

12th World Congress on Cell & Tissue Science

Singapore
October 21-22, 2019

23rd European Biotechnology Congress

Zurich, Switzerland
November 26-27, 2019

International Conference On Genomics and Molecular Biology

Lisbon | Portugal
November 26-27, 2019

International Conference on Cell and Gene Therapy

| Lisbon, Portugal
February 24-25, 2020

24th Global Congress on Biotechnology

London, UK
March 16-17, 2020 |

12th World Congress and Expo on Cell & Stem Cell Research

Chicago, Illinois, USA
May 21-22, 2020

24th European Biotechnology Congress

London,UK

Epigenetic Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in